Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures.
Détails
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_E70DD8E56C37
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures.
Périodique
Open forum infectious diseases
ISSN
2328-8957 (Print)
ISSN-L
2328-8957
Statut éditorial
Publié
Date de publication
02/2024
Peer-reviewed
Oui
Volume
11
Numéro
2
Pages
ofae023
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Publication Status: epublish
Résumé
The interpretation of long-acting cabotegravir and rilpivirine concentrations is complicated by the lack of consensus on the threshold to consider. Building on real-world therapeutic drug monitoring data and documented virologic failures, this article provides a reappraisal of the existing thresholds and guidance for the interpretation of cabotegravir and rilpivirine concentrations.
Mots-clé
Infectious Diseases, Oncology, TDM, cabotegravir, guidance, long-acting, rilpivirine
Pubmed
Web of science
Open Access
Oui
Création de la notice
23/01/2024 14:47
Dernière modification de la notice
06/08/2024 6:02
Données d'usage
